RAS inhibitor (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RAS inhibitor (investigational), covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations [Phase 1]